Clinical Trial Update: Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung [Phase 3]

View source ↗

Summary

Phase 3 trial update on Abenacianine (VGT-309) to identify cancer during lung cancer surgery; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Lung Metastases

Drugs mentioned

• Abenacianine

Snippet

Sponsor: Vergent Bioscience, Inc. | Conditions: Lung Cancer, Lung Metastases | Phase 3 | Status: RECRUITING